Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Titel:
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Auteur:
Leonardi, Craig L Kimball, Alexa B Papp, Kim A Yeilding, Newman Guzzo, Cynthia Wang, Yuhua Li, Shu Dooley, Lisa T Gordon, Kenneth B